COVID-19, Influenza A/B, Seasonal Influenza A subtyping, Influenza A/H5 and Influenza A/H7 Extraction Reagents

The Naval Medical Research Command (NMRC) is seeking to award a sole source contract to Roche Diagnostics Corporation for the purchase of reagents for COVID-19, Influenza A/B, Seasonal Influenza A subtyping, Influenza A/H5, and Influenza A/H7 extraction. The contract will be for a total of 4,000 reactions, with four bi-monthly shipments of 1,000 reactions each. The specific items to be purchased include MagNA Pure 96 Processing Cartridges, MagNA Pure Filter Tips, MagNA Pure External Lysis Buffer, MagNA Pure 96 DNA and Viral NA SV Kit, and MagNA Pure 96 System Fluid. * The contract is for a sole source award to Roche Diagnostics Corporation. * The contract is for the purchase of reagents for COVID-19, Influenza A/B, Seasonal Influenza A subtyping, Influenza A/H5, and Influenza A/H7 extraction. * The contract will be for a total of 4,000 reactions, with four bi-monthly shipments of 1,000 reactions each. * The specific items to be purchased include MagNA Pure 96 Processing Cartridges, MagNA Pure Filter Tips, MagNA Pure External Lysis Buffer, MagNA Pure 96 DNA and Viral NA SV Kit, and MagNA Pure 96 System Fluid. * The contract will be procured under the guidelines of FAR Part 12 Commercial Items. * The NAICS code for this action is 325413.